The influence of bovine casein-derived exorphins on mast cells in rodents

Revue Francaise d'Allergologie et d'Immunologie Clinique

Volumn 42, Issue 5, 2002, Pages 447-453

  Stpnik, M ^a   Kurek, M ^b  

^a NOFER INSTITUTE OF OCCUPATIONAL MEDICINE   (Poland)

^b POMERANIAN MEDICAL UNIVERSITY   (Poland)

Author keywords

Casein: 90 95; Casomorphin 7; Hexosaminidase activity; Mouse bone marrow derived "mucosal like" mast cells; Rat peritoneal mast cells; Secretory effect of casein: 90 95

Indexed keywords

BENZALKONIUM CHLORIDE; BETA CASOMORPHINE 7; BETA CASOMORPHINE DERIVATIVE; CASEIN; EDETIC ACID; EXORPHIN; NALOXONE; OPIATE AGONIST; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; IMMUNOMODULATION; MAST CELL DEGRANULATION; NONHUMAN; PERITONEUM MAST CELL; PROTEIN PROTEIN INTERACTION; RAT; SIGNAL TRANSDUCTION; STIMULUS SECRETION COUPLING;

EID: 0036741425     PISSN: 03357457     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0335-7457(02)00176-4     Document Type: Article

References (28)

1. Zioudrou C, Streaty RA, Klee WA. Opioid peptides derived from food proteins. The exorphins. J Biol Chem 1979;254:2446-9.
2. Kreil G, Umbach M, Brantl V, Teschemacher H. Studies on the enzymatic degradation of beta-casomorphins. Life Sci 1983;33:137-40.
3. Morley JE. Food peptides: a novel class of hormones? JAMA 1982;247:2379-80.
4. Kurek M, Babic R, Laimgruber D, Erhardt W, Ring J. β-Casomorphin induced anaphylactoid reactions in guinea pigs. Alergo J 1995;4:223-8.
5. Kurek M, Przybilla B, Hermann K, Ring J. A naturally occurring opioid peptide from cow's milk, beta-casomorphin-7 is a direct histamine releaser in man. Int Arch Allergy Immunol 1992;97:115-20.
6. Kurek M, Ruëff F, Czerwionka-Szaflarska M, Doroszewska G, Przybilla B. Exorphins derived from cow's milk casein elicit pseudo-allergic wheal-and-flare reactions in healthy children. Rev Fr Allergol 1996;36:191-6.
7. Svedberg J, de Haas Leimenstool G, Paul F, Teschemacher H. Demonstration of β-casomorphin immunoreactive materials in in vitro digests of bovine milk and small intestine contents after bovine milk ingestion in adult humans. Peptides 1985;6:825-30.
8. Brantl V, Teschemacher H. A material with opioid activity in bovine milk and milk products. Naunyn-Schiedeberg's. Arch Pharmacol 1979;306:301-4.
9. Razin E, Cordon-Cardo C, Good RA. Growth of pure population of mouse mast cells in vitro with conditioned medium derived from concanavalin A-stimulated splenocytes. Proc Natl Acad Sci USA 1982;28:2559-61.
10. Wingren V, Enerback L. Mucosal mast cells of the rat intestinal: a reevaluation of fixation and staining properties, with special reference to protein blocking and solubility of the granular glycosaminoglycans. Histochemistry 1983;15:571-82.
11. Rossow N, Savoly SB, Repke H, Odarjuk J. Monoclonal antibodies against rat mast cells. Biomed. Biochim. Acta 1986;45:1343-7.
12. Babich H, Borenfreund E. Applications of the neutral red cytotoxicity assay to in vitro toxicology. Alternatives Laboratory Animals 1990;18:129-44.
13. Reader SJ, Blackwell V, O'Hara R, Clothier RH, Griffin G, Balls M. A vital dye release method for assessing the short-term cytotoxic effects of chemicals and formulations. Alternatives. Laboratory Animals 1989;17:28-33.
14. INVITOX. The Frame Neutral Red Uptake Assay. The ERGATT/FRAME data bank of in vitro techniques in toxicology. INVITOX Protocol 3b 1990b ISSN: 0960-2194.
15. Levi-Shaffer F, Riesel N. In vitro regeneration of activated rat peritoneal mast cells cocultured with fibroblasts. Cellular Immunol 1989;119:30-40.
16. Levi-Shafer F, Rubinchik E. Mast cell/fibroblast interactions. Clin Experimental Allergy 1994;24:1016-21.
17. INVITOX. The FRAME Neutral Red Release Assay. The ERGATT/FRAME data bank of in vitro techniques in toxicology. INVITOX Protocol 54 1990b ISSN: 0960-2194.
18. Teschemacher HJ, Koch G, Schefler H, Hildebrand A, Brantl V. Opioid peptides. Immunological significance? Ann NY Acad Sci 1990;594:66-77.
19. Casale TB, Bowman S, Kaliner M. Induction of human cutaneous mast cell degranulation by opiates and endogenous opioid peptides: evidence for opiate and non-opiate receptor participation. J Allergy Clin Immunol 1984;73:413-8.
20. Lorenz W. Doenicke B, Meyer B, Reimann HJ, Kusche J, Barth H, Geesing H, Hutzel M, Weissenbacher B. Histamine release in man by propainid and thiopentone: pharmacological effects and clinical consequences. Br J Anaesth 1972;44:335-68.
21. Arock M, Devillier P, Luffau G, Guillosson JJ, Renoux M. Histamine-releasing activity of endogenous peptides on mast cells derived from different sites and species. Int Arch Allergy Appl Immunol 1989;89:229-35.
22. Shanahan F, Lee TDG, Bienenstock J, Befus AD. The influence of endorphins on peritoneal and mucosal mast cell secretion. J Allergy Clin Immunol 1984;74:499-504.
23. Landry Y, Bronner C, Mousli M, Fischer T, Valle A. The activation of mast cells: molecular and transducing processes for antigenic and non-antigenic stimuli. Bull Inst Pasteur 1992;90:83-98.
24. i-like proteins, a receptor-independent effect of kinins in mast cells. Mol Pharmacol 1990b;38:816-22.
25. Mousli M, et al. Structural requirements for neuropeptide Y in mast cell and G protein activation. Eur J Pharmacol 1995;289:125-33.
26. Malaviya R, Ikeda T, Ross E, Abraham SN. Mast cell modulation of neutrophil influx and bacterial clearance at sites of infection through TNF-α. Nature 1996;381:77-9.
27. Bischoff SC, Schwengberg S, Wordelmann K, Weimannn A, Raab R, Manns MP. Effect of c-kit ligand, stem cell factor, on mediator release by human intestinal mast cells isolated from patients with inflammatory bowel disease and controls. Gut 1996;38:104-14.
28. Kurek M, Malaczynska T. Nutritive casein formula elicit pseudoallergic skin reactions by prick testing. Int Arch Allergy Immunol 1999;118:228-9.